This study aimed to explore the stigma, barriers, and improvements needed for providing effective mental health care in community pharmacies in Jordan. A qualitative study was conducted through semi-structured interviews with 20 community pharmacists. The interviews were conducted in December 2024. Thematic analysis was applied to identify themes. A total of 20 pharmacists were interviewed. Pharmacists reported significant stigma among patients with mental health disorders, often due to societal pressures. However, within the pharmacy environment, pharmacists showed minimal stigma and demonstrated empathy. Key barriers identified included communication challenges, particularly the lack of privacy. Proposed improvements focused on enhancing education and training through workshops and continuous professional development. Community pharmacists play a critical role in mental health care but face challenges such as stigma, communication issues, and knowledge gaps. Addressing these barriers through better training could significantly enhance the ability of pharmacists to provide effective mental health support.
AaltonenSELaineNPVolmerD, et al. (2010) Barriers to medication counselling for people with mental health disorders: A six country study. Pharmacy Practice8(2): 122–131.
2.
AkourAHalloushSNusairMB, et al. (2022) Gaps in pharmaceutical care for patients with mental health issues: A cross-sectional study. International Journal of Clinical Pharmacy44(4): 904–913.
3.
Al-KrenawiA (2005) Mental health practice in Arab countries. Current Opinion in Psychiatry18(5): 560–564.
4.
Al-QeremWJarabAKhdourM, et al. (2024) Assessing mental health literacy in Jordan: A factor analysis and Rasch analysis study. Frontiers in Public Health12: 1396255.
5.
AltobaishatOAbouzidMOmariD, et al. (2025) Examining the burden of mental disorders in Jordan: An ecological study over three decades. BMC Psychiatry25(1): 218.
6.
AluhDOAnyachebeluOCAjaraonyeCI (2020) Comparison of pharmacists’ mental health literacy: Developed versus developing countries. Journal of the American Pharmaceutical Association60(5): S64–S72.
7.
BatarsehYAbukhalafMFakhouryR, et al. (2022) Mental health literacy and stigma towards patients with mental health disorders among pharmacists in the MENA region. Journal of Pharmaceutical Health Services Research13(2): 143–150.
8.
BinghamJAxonDRScovisN, et al. (2018) Evaluating the effectiveness of clinical pharmacy consultations on nutrition, physical activity, and sleep in improving patient-reported psychiatric outcomes for individuals with mental illnesses. Pharmacy7(1): 2.
9.
ChenJWangY (2021) Social media use for health purposes: Systematic review. Journal of Medical Internet Research23(5): e17917.
10.
ChestonCCFlickingerTEChisolmMS (2013) Social media use in medical education: A systematic review. Academic Medicine88(6): 893–901.
11.
ClementSSchaumanOGrahamT, et al. (2015) What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychological Medicine45(1): 11–27.
12.
CollinsJCNgRMcMillanSS, et al. (2023) Psychological distress in community-dwelling individuals living with severe and persistent mental illness. International Journal of Social Psychiatry69(6): 1327–1334.
13.
DalkyHF (2012) Arabic translation and cultural adaptation of the stigma-devaluation scale in Jordan. Journal of Mental Health21(1): 72–82.
14.
DmourHHMarashdehMFAl-ZubiAK, et al. (2020) Stigma of mental illness in Jordan. Journal of the Royal Medical Services27(1): 70–75.
15.
El-DenSCollinsJCChenTF, et al. (2021) Pharmacists’ roles in mental healthcare: Past, present and future. Pharmacy Practice19(3): 2545.
16.
GBD (2022) Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. Lancet Psychiatry9(2): 137–150.
17.
GearingREMacKenzieMJIbrahimRW, et al. (2015) Stigma and mental health treatment of adolescents with depression in Jordan. Community Mental Health Journal51: 111–117.
18.
HammettTMPhanSGagginJ, et al. (2014) Pharmacies as providers of expanded health services for people who inject drugs: A review of laws, policies, and barriers in six countries. BMC Health Services Research14(1): 11.
19.
HareSKKraenowK (2008) Depression screenings: Developing a model for use in a community pharmacy. Journal of the American Pharmaceutical Association48(1): 46–52a.
20.
HattinghHLEmmertonLNg Cheong TinP, et al. (2016) Utilization of community pharmacy space to enhance privacy: A qualitative study. Health Expectations19(5): 1098–1110.
21.
KnoxKKellyFMeyA, et al. (2015) Australian mental health consumers’ and carers’ experiences of community pharmacy service. Health Expectations18(6): 2107–2120.
22.
LiekensSSmitsTLaekemanG, et al. (2012) Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. International Journal of Clinical Pharmacy34: 452–459.
23.
McMillanSSStapletonHStewartV, et al. (2020) A qualitative study exploring opportunities for pharmacists to connect with young mental health consumers. Journal of the American Pharmaceutical Association60(5): S23–S33.
24.
MillerPNewbyDWalkomE, et al. (2020) Depression screening in adults by pharmacists in the community: A systematic review. International Journal of Pharmacy Practice28(5): 428–440.
25.
MoradinazarMMirzaeiPMoradivafaS, et al. (2022) Epidemiological status of depressive disorders in the Middle East and North Africa from 1990 to 2019. Health Promotion Perspectives12(3): 301–309.
26.
MurphyALPhelanHHaslamS, et al. (2016) Community pharmacists’ experiences in mental illness and addictions care: A qualitative study. Substance Abuse Treatment Prevention and Policy11(1): 14.
27.
O’DonnellDCBrownCMDastaniHB (2006) Barriers to counseling patients with obesity: A study of Texas community pharmacists. Journal of the American Pharmaceutical Association46(4): 465–471.
28.
O’ReillyCLWongEChenTF (2015) A feasibility study of community pharmacists performing depression screening services. Research in Social and Administrative Pharmacy11(3): 364–381.
29.
ObaisatMAAl-AlwanMM (2020) Stigma of mental illness in Jordan. Journal of the Royal Medical Services27(1): 70–75.
30.
RileyTBAlemagnoS (2019) Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients. Research in Social and Administrative Pharmacy15(8): 986–991.
31.
RosserSFredeSConradWF, et al. (2013) Development, implementation, and evaluation of a pharmacist-conducted screening program for depression. Journal of the American Pharmaceutical Association53(1): 22–29.
32.
Rubio-ValeraMChenTFO’ReillyCL (2014) New roles for pharmacists in community mental health care: A narrative review. International Journal of Environmental Research and Public Health11(10): 10967–10990.
33.
SaminanSJulisafridaLSaminanNF, et al. (2024) The relationship between anxiety and quality of life: A bibliometric analysis. AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh10(2): 80–90.
34.
ScheerderGDe CosterIVan AudenhoveC (2009) Community pharmacists’ attitude toward depression: A pilot study. Research in Social and Administrative Pharmacy5(3): 242–252.
35.
VenetiaNEvangeliaSChristinaD, et al. (2022) Pharmacists’ knowledge, attitudes and practices towards people with mental health problems: A cross-sectional study. International Journal of Caring Sciences15(3): 1904–1911.
36.
VironMJSternTA (2010) The impact of serious mental illness on health and healthcare. Psychosomatics51(6): 458–465.
37.
WheelerJSChisholm-BurnsM (2018) The benefit of continuing professional development for continuing pharmacy education. American Journal of Pharmaceutical Education82(3): 6461.
38.
WhitefordHAFerrariAJDegenhardtL, et al. (2015) The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010. PLoS One10(2): e0116820.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
